Amostra

Experimente por R$ 0,00

R$ 19,90 /mês

R$ 19,90/mês após o teste gratuito de 30 dias. Cancele a qualquer momento.
Curta mais de 100.000 títulos de forma ilimitada.
Ouça quando e onde quiser, mesmo sem conexão
Sem compromisso. Cancele a qualquer momento.

N of 1

De: Glenn Sabin, Dawn Lemanne MD MPH - contributor, Dean Ornish MD - foreword
Narrado por: Charles Constant
Assine - Grátis por 30 dias

Depois de 30 dias, R$ 19,90/mês. Cancele quando quiser.

Compre agora por R$ 35,99

Compre agora por R$ 35,99

Pagar usando o cartão terminado em
Ao confirmar sua compra, você concorda com as Condições de Uso da Audible e a Política de Privacidade da Amazon. Impostos, quando aplicável. PRECISA SER AJUSTADO

Sinopse

Twenty-five years ago, my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story....

In 1991, Glenn Sabin was a 28-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL) - a disease doctors called "uniformly fatal". Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: He was going to die.

Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists, and top oncologists, Glenn made a monumental decision: He would become his own health advocate. While he continued to "watch and wait", Glenn would figure out how to stay alive.

No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own medically monitored and carefully researched lifestyle changes. He would conduct his own single-patient clinical trial.

He would become an "n of one".

Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.

©2016 FON Therapeutics, Inc. (P)2020 Tantor

O que os ouvintes dizem sobre N of 1

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.